Vita 34 AG
XETRA:V3V
Vita 34 AG
XETRA:V3V
Price:
4.7 EUR
-1.26%
Market Closed
Updated:
May 9, 2024
Vita 34 AG
Interest Income Expense
|
Vita 34 AG
Interest Income Expense Peer Comparison
Comparables:
F
FME
F
FRE
E
1846
SYAB
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vita 34 AG
XETRA:V3V
|
Interest Income Expense
-€3.8m
|
CAGR 3-Years
-246%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
-45%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Interest Income Expense
-€250.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Interest Income Expense
-€428m
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Interest Income Expense
HK$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Synlab AG
XETRA:SYAB
|
Interest Income Expense
€101.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Interest Income Expense?
Interest Income Expense
-3.8m
EUR
-3.8m
EUR
Based on the financial report for Sep 30, 2023, Vita 34 AG's Interest Income Expense amounts to -3.8m EUR.
What is Vita 34 AG's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-45%
-45%
Over the last year, the Interest Income Expense growth was -468%. The average annual Interest Income Expense growth rates for Vita 34 AG have been -246% over the past three years , -69% over the past five years , and -45% over the past ten years .
You don't have any saved screeners yet
